Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty

BACKGROUND: The use of antifibrinolytic medications in hip and knee arthroplasty reduces intraoperative blood loss and decreases transfusion rates postoperatively. Tranexamic acid (TXA) specifically has not been associated with increased thromboembolic (TE) complications, but concerns remain about t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gillette, Blake P., DeSimone, Lori J., Trousdale, Robert T., Pagnano, Mark W., Sierra, Rafael J.
Formato: Artigo
Idioma:Inglês
Publicado: Springer-Verlag 2012
Assuntos:
Symposium: Papers Presented at the Annual Meetings of the Knee Society
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528901/
https://ncbi.nlm.nih.gov/pubmed/22814857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-012-2488-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares